In a caerulein-induced AP mouse model, celastrol treatment was shown to reduce serum amylase levels, lower histopathological scores, suppress pancreatic p-MLKL expression, and decrease the number of necrotic acinar cells. Here, MLKL is linked to alkaline phosphatase measurement.